Skip to main content

US ClosedU.S. Closed

VSTM: Verastem, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Verastem, Inc. is an emerging biopharmaceutical company dedicated to the creation and commercialization of innovative therapeutic agents for cancer treatment.

52W Range

48thpctl

Volume

0.44×avg

Market Cap

634.45MUSD

P/E Ratio

-2.9TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Verastem, Inc.

VSTMNASDAQ Global Market·USD·Closed

Verastem, Inc.

VSTMNASDAQ·USD·Closed

$7.22

−2.17%

$7.22

−$0.16 (2.17%)

52W Range

48thpctl

Volume

0.44×avg

Mkt Cap

634.45MUSD

P/E

-2.9TTM

Div Yield

–ann